Focal Points

*/ ?>

Latest Episodes:

Making Deep Brain Stimulation Minimally Invasive with MJ Antonini and Nicki Driscoll of NeuroBionics Sep 30, 2024

Today’s guests are MJ Antonini & Nicki Driscoll, the founders of NeuroBionics, a neurotech startup out of MIT. NeuroBionics is making Deep Brain Stimulation minimally invasive though the development of nano fibers that are 10X thinner than traditional Deep Brain Stimulation leads - allowing them to be inserted endovascularly into the brain. Check out NeuroBionics at https://neurobionics.io/

Advancements in Male Sexual Health w/ John Boghossian & Ryan Protzko of Kadence Bio Apr 30, 2024

Can a succulent plant from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kadence Bio think so.

www.kadencebio.com

Can Skull Implants Treat Depression? Jacob Robinson & Motif Neurotech (Crossover Episode on Business Trip) Oct 23, 2023

Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still!

Jacob Robinson from Motif Neurotech discusses the future of minimally invasive electronic medicine from mental health and beyond.

This is a crossover episode from the Business Trip podcast.

Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics Jun 30, 2022

Sam Banister is a medicinal chemist and co-founder of Psylo. Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic medicines to treat mental illness.

Sam is here to help us understand how new chemical entities are reshaping the psychedelic field; how novel psychedelic molecules are made, and how new chemical entities are going to play a dominant role in the future of psychedelic medicine.

Make sure to subscribe to the show!

Follow Brom on twitter: https://twitter.com/therealbrom

Follow Sam on twitter: https://twitter.com/samuel_b_phd

Brom's VC Fund: https://www.empath.vc

Highlighted Timestamps:

06:12 - Are next generation psychedelics taking over in 10 years?

16:10 - What is the process like for creating a new chemical entities?

50:39 - Psychedelics vs Cannabis: New drug discoveries

Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment Mar 27, 2022

Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.

In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction. Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.

https://www.beond.us

Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator Feb 10, 2022

Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.

Mindstate's mission is to map the biological basis of the varieties of psychedelic experience, and to use that map to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders. Mindstate participated in Y Combinator in 2021.

Check out Mindstate @ https://www.mindstate.design/

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected